Pabst Brooke M, Leung Cynthia, Frey Jennifer A, Yee Jennifer
The Ohio State University, Department of Emergency Medicine, Columbus, OH.
J Educ Teach Emerg Med. 2020 Oct 15;5(4):S59-S83. doi: 10.21980/J85352. eCollection 2020 Oct.
This scenario was developed to educate emergency medicine residents about the diagnosis and management of the agitated psychiatric patient.
The prevalence of agitation among patients in the emergency department is increasing, with an estimated 1.7 million events occurring annually in the United States.1 There are various methodologies for de-escalation, including verbal and chemical de-escalation and physical restraints. Chemical and/or physical restraints are sometimes necessary to ensure patient and staff safety when verbal de-escalation is ineffective, particularly since agitation is the leading cause of hospital staff injuries.2 Chemical restraints have been shown to be less physically traumatizing to patients.3 4 Adverse events associated with physical restraints include persistent psychological distress, blunt chest trauma, aspiration, respiratory depression, and asphyxiation leading to cardiac arrest.5 In regards to chemical restraints, adverse event reporting has been heterogeneous among studies, but the most consistent reported events involve respiratory compromise such as desaturation, airway obstruction, and respiratory depression.3 A study measuring QTc (corrected QT interval) after high-dose intramuscular ziprasidone or haloperidol did not demonstrate any QTc longer than 480 msec.6 Other events linked to chemical restraints include uncommon cardiovascular events and extrapyramidal side effects from medications.3 The main classes of medications utilized for chemical restraint include first-generation antipsychotics (eg, haloperidol and droperidol), second-generation antipsychotics (olanzapine, quetiapine, risperidone, aripiprazole, and ziprasidone), benzodiazipenes (eg, lorazepam and midazolam), and N-methyl-D-aspartic acid (NMDA) receptor antagonists (eg, ketamine).7,8 It is important to exclude other medical causes of agitation, consider the differential diagnoses, and then select a medication that is tailored to address underlying etiologies while remaining cognizant of the side effect profiles of these chemical agents.: At the conclusion of the simulation session, learners will be able to: 1) Obtain a relevant focused history and physical examination on the agitated psychiatric patient. 2) Develop a differential for the agitated psychiatric patient, including primary psychiatric conditions and other organic pathologies. 3) Discuss the management of the agitated psychiatric patient, including the different options available for chemical sedation. 4) Prioritize safety of self and staff when caring for an agitated psychiatric patient.
This session was conducted using simulation with a standardized patient, followed by a debriefing session and lecture on the presentation, differential diagnosis, and management of the agitated psychiatric patient. Debriefing methods may be left to the discretion of participants, but the authors have utilized advocacy-inquiry techniques. This scenario may also be run as an oral board examination case.
The residents are provided a survey at the completion of the debriefing session to rate different aspects of the simulation, as well as provide qualitative feedback on the scenario. This survey is specific to the local institution's simulation center.
Feedback from the residents was overwhelmingly positive, although many stated that they felt some degree of intimidation or stress from the standardized patient who did not break from their role throughout the scenario.The local institution's simulation center feedback form is based on the Center of Medical Simulation's Debriefing Assessment for Simulation in Healthcare (DASH) Student Version Short Form9 with the inclusion of required qualitative feedback if an element was scored less than a 6 or 7. This session received mostly 7 scores (extremely effective/outstanding).
This is a physically safe method for reviewing management of the agitated psychiatric patient. There are multiple potential presentations of the agitated psychiatric patient, as well as varying underlying etiologies. These scenarios may be tailored to the needs of the learner, including identifying agitation, pharmacologic review, and de-escalation techniques.
Medical simulation, agitated psychiatric patient, chemical sedation, verbal de-escalation, emergency medicine, psychiatry.
设计此情景是为了培训急诊医学住院医师,使其了解躁动精神病患者的诊断和管理。
急诊科患者中躁动的发生率正在上升,在美国估计每年发生170万起此类事件。1有多种缓和措施,包括言语和药物缓和以及身体约束。当言语缓和无效时,有时需要使用药物和/或身体约束来确保患者和工作人员的安全,特别是因为躁动是医院工作人员受伤的主要原因。2已证明药物约束对患者造成的身体创伤较小。3 4与身体约束相关的不良事件包括持续的心理困扰、钝性胸部创伤、误吸、呼吸抑制和导致心脏骤停的窒息。5关于药物约束,不同研究中不良事件的报告存在差异,但最一致报告的事件包括呼吸功能受损,如血氧饱和度下降、气道阻塞和呼吸抑制。3一项测量高剂量肌内注射齐拉西酮或氟哌啶醇后QTc(校正QT间期)的研究未发现QTc超过480毫秒。6与药物约束相关的其他事件包括罕见的心血管事件和药物引起的锥体外系副作用。3用于药物约束的主要药物类别包括第一代抗精神病药(如氟哌啶醇和氟哌利多)、第二代抗精神病药(奥氮平、喹硫平、利培酮、阿立哌唑和齐拉西酮)、苯二氮䓬类药物(如劳拉西泮和咪达唑仑)以及N-甲基-D-天冬氨酸(NMDA)受体拮抗剂(如氯胺酮)。7,8排除躁动的其他医学原因、考虑鉴别诊断,然后选择一种适合解决潜在病因的药物,同时了解这些化学制剂的副作用,这一点很重要。在模拟课程结束时,学习者将能够:1)对躁动精神病患者进行相关的重点病史询问和体格检查。2)列出躁动精神病患者的鉴别诊断,包括原发性精神疾病和其他器质性病变。3)讨论躁动精神病患者的管理,包括药物镇静的不同选择。4)在护理躁动精神病患者时,将自身和工作人员的安全放在首位。
本课程采用标准化患者模拟进行,随后进行总结讨论,并就躁动精神病患者的表现、鉴别诊断和管理进行讲座。总结讨论方法可由参与者自行决定,但作者采用了支持性询问技巧。此情景也可作为口试病例进行。
在总结讨论结束时,向住院医师提供一份调查问卷,以对模拟的不同方面进行评分,并就该情景提供定性反馈。该调查问卷是针对当地机构的模拟中心设计的。
住院医师的反馈总体上是积极的,尽管许多人表示,他们对在整个情景中未脱离角色的标准化患者感到一定程度的 intimidation(此处原文可能有误,推测为intimidation,意为“ intimidation”)或压力。当地机构模拟中心的反馈表基于医疗模拟中心的医疗保健模拟总结评估(DASH)学生版简表9,并在某个元素得分低于6或7时纳入所需的定性反馈。本次课程大多获得7分(极其有效/出色)。
这是一种在身体上安全的方法,用于复习躁动精神病患者的管理。躁动精神病患者有多种可能的表现形式,以及不同的潜在病因。这些情景可以根据学习者的需求进行调整,包括识别躁动、药物复习和缓和技巧。
医学模拟、躁动精神病患者、药物镇静、言语缓和、急诊医学、精神病学。